Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.

Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.

Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.

Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.

Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.

Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.

Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.

cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.

tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.

amikacin as initial therapy of febrile episodes in neutropenic patients.

Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.

Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.

Vancomycin dosing in neutropenic patients.

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.

Septicaemia in febrile neutropenic children with cancer in Saudi Arabia.

Neutropenic fever.

A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.

A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.

A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.

Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication.

A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.

Suggest Documents

Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.

Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.

Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.

Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.

Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.

Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

Imipenem-cilastatin for empirical therapy in neutropenic patients with fever: an open study in patients with hematologic malignancies.

Aztreonam plus vancomycin versus gentamicin plus piperacillin as empirical therapy for the treatment of fever in neutropenic patients: a randomised controlled study.

A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies.

cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.

tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy.

amikacin as initial therapy of febrile episodes in neutropenic patients.

Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.

Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study.

Vancomycin dosing in neutropenic patients.

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone.

Septicaemia in febrile neutropenic children with cancer in Saudi Arabia.

Neutropenic fever.

A randomized trial of ciprofloxacin plus azlocillin versus netilmicin plus azlocillin for the empirical treatment of fever in neutropenic patients.

A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.

A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.

Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication.

A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.

Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.

Recommend Documents

Follow Us